GlamBud® will identify prospective community members using metrics, available subscription lists and public relations events. Those identified will be solicited with a personal invitation for a ‘no-risk’ trial.It is anticipated that with rich, balanced content and promotional offerings, GlamBud will activate and engage over one million aesthetics patients in the US by 2022.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.